P. Desjeux, Worldwide increasing risk factors for leishmaniasis, Medical Microbiology and Immunology, vol.190, issue.1-2, pp.77-79, 2001.
DOI : 10.1007/s004300100085

M. Mohebali, Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran, Acta Tropica, vol.103, issue.1, pp.33-40, 2007.
DOI : 10.1016/j.actatropica.2007.05.005

H. Hajjaran, Identification of Leishmania species isolated from human cutaneous Leishmaniasis, using RAPD-PCR, Iranian Journal of Public Health, vol.33, pp.8-15, 2004.

C. Davies, Leishmaniasis: new approaches to disease control, BMJ, vol.326, issue.7385, pp.377-382, 2003.
DOI : 10.1136/bmj.326.7385.377

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125241

R. Rojas, Resistance to antimony and treatment failure in human Leishmania (Viannia) infection, Journal of Infectious Diseases, vol.15, pp.1375-1383, 2006.

R. Hadighi, Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites, PLoS Medicine, vol.29, issue.5, p.162, 2006.
DOI : 10.1371/journal.pmed.0030162.sd002

S. Croft and R. Brun, In vitro and in vivo models for the identification and evaluation of drugs active against Trypanosoma and Leishmania, Drugs against parasitic diseases: R&D methodologies and issues, pp.165-175, 2003.

J. Alvar, S. Croft, and P. Olliaro, Chemotherapy in the Treatment and Control of Leishmaniasis, Advances in Parasitology, vol.61, pp.223-274, 2006.
DOI : 10.1016/S0065-308X(05)61006-8

J. Berman, D. Chulay, and C. Oster, Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro, American Journal of Tropical Medicine and Hygiene, pp.31459-465, 1982.

J. Berman, J. Gallalee, and . Abg, Sodium stibogluconate (Pentostam ) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes, Biochemical Pharmacology, vol.36, pp.197-201, 1987.

H. Callahan and S. Beverley, A member of the aldoketo reductase family confers methotrexate resistance in Leishmania, Journal of Biological Chemistry, vol.267, pp.24165-24168, 1992.

B. Papadopoulou, G. Roy, and M. Ouellette, A novel antifolate resistance gene on the amplified H circle of Leishmania, EMBO Journal, vol.11, pp.3601-3608, 1992.

S. Croft, S. Sundar, and A. Fairlamb, Drug Resistance in Leishmaniasis, Clinical Microbiology Reviews, vol.19, issue.1, pp.111-126, 2006.
DOI : 10.1128/CMR.19.1.111-126.2006

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360270

C. Guimond, Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays, Nucleic Acids Research, vol.31, issue.20, pp.5886-5896, 2003.
DOI : 10.1093/nar/gkg806

B. Vergnes, A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell Death, Molecular & Cellular Proteomics, vol.6, issue.1, pp.88-101, 2007.
DOI : 10.1074/mcp.M600319-MCP200

URL : https://hal.archives-ouvertes.fr/hal-00170702

H. Hajjaran, Protein profiling on meglumine antimoniate (glucantime (r)) sensitive and resistant L. tropica isolates by 2-dimentional gel electrophoresis: a preliminary study, Iranian Journal of Parasitology, vol.4, pp.8-14, 2009.

M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-254, 1976.
DOI : 10.1016/0003-2697(76)90527-3

A. Shevchenko, Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels, Analytical Chemistry, vol.68, issue.5, pp.850-858, 1996.
DOI : 10.1021/ac950914h

B. Papadopoulou and J. Drummelsmith, Proteomics to explore pathogenesis and drug resistance mechanisms in protozoan parasites Biomedical and pharmaceutical applications of proteomics, 2004.

J. Drummelsmith, Differential Protein Expression Analysis of Leishmania major Reveals Novel Roles for Methionine Adenosyltransferase and S-Adenosylmethionine in Methotrexate Resistance, Journal of Biological Chemistry, vol.279, issue.32, pp.33273-33280, 2004.
DOI : 10.1074/jbc.M405183200

E. Fakhry, Y. Ouellette, M. Papadopoulou, and B. , A proteomic approach to identify developmentally regulated proteins in Leishmania infantum, PROTEOMICS, vol.2, issue.8, pp.1007-1017, 2002.
DOI : 10.1002/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G

N. Acestor, Establishing two-dimensional gels for the analysis of Leishmania proteomes, PROTEOMICS, vol.2, issue.7, pp.877-879, 2002.
DOI : 10.1002/1615-9861(200207)2:7<877::AID-PROT877>3.0.CO;2-D

S. Ahmed, A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major, Vaccine, vol.22, issue.13-14, pp.1631-1639, 2004.
DOI : 10.1016/j.vaccine.2003.10.046

B. Kelly, S. Dbal, and M. Richard, Leishmania major LACK antigen is required for efficient vertebrate parasitization, Journal of Experimental Medicine, issue.11, pp.1981689-1698, 2003.
DOI : 10.1084/jem.20031162

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194132

S. Ashutosh and N. Goyal, Molecular mechanisms of antimony resistance in Leishmania, Journal of Medical Microbiology, vol.56, issue.2, pp.143-153, 2007.
DOI : 10.1099/jmm.0.46841-0

P. Leprohon, Modulation of Leishmania ABC Protein Gene Expression through Life Stages and among Drug-Resistant Parasites, Eukaryotic Cell, vol.5, issue.10, pp.1713-1725, 2006.
DOI : 10.1128/EC.00152-06

A. Zai, Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, Journal of Clinical Investigation, vol.103, issue.3, pp.393-399, 1999.
DOI : 10.1172/JCI4890

Z. Kabututu, Prostaglandin production from arachidonic acid and evidence for a 9,11-endoperoxide prostaglandin H2 reductase in Leishmania, International Journal for Parasitology, vol.32, issue.14, pp.1693-1700, 2002.
DOI : 10.1016/S0020-7519(02)00160-1

J. Drummelsmith, Proteome Mapping of the Protozoan Parasite Leishmania and Application to the Study of Drug Targets and Resistance Mechanisms, Molecular & Cellular Proteomics, vol.2, issue.3, pp.146-155, 2003.
DOI : 10.1074/mcp.M200085-MCP200